Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide injection (Wegovy) is taken once a week, on any day that suits you — morning, afternoon or evening, with or without food. The most important thing is keeping that day consistent: the same weekday, every week, spaced as close to seven days apart as possible. Because semaglutide stays active in the body for around a week, irregular timing can affect how steady your levels remain. These medicines are prescription-only, and your prescriber will confirm the schedule that fits your individual treatment plan.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
No, but once chosen, that day should stay fixed. Wegovy's active ingredient, semaglutide, has a half-life of roughly seven days, which is why a once-weekly schedule works biologically. Changing your injection day every week disrupts the steady state the medicine is trying to maintain, and some people notice more side effects, particularly nausea, when levels fluctuate.
Practically, most people pick a day that anchors itself to something else: a Sunday evening before the working week, a Friday morning when there's more time. The NHS recommends choosing a day you are confident you can stick to long-term. If you ever need to shift your injection day (for travel or a schedule change) your prescriber can advise on bridging the gap safely.
For a fuller look at when to take your Wegovy injection across different situations, including holidays and shift work, our dedicated guide covers the practical scenarios most people actually face.
Officially, no. The NHS semaglutide medicine guide confirms that Wegovy can be taken at any time of day, with or without a meal. Unlike oral semaglutide (the Wegovy tablet, taken first thing on an empty stomach), the injection bypasses the digestive system entirely, absorption happens subcutaneously, so food has no meaningful effect on how much medicine reaches your bloodstream.
That said, many people find a consistent time of day helpful for habit-building. Evening injections suit those who notice nausea in the first hour or two after dosing, since they sleep through most of it. Morning injections work well for people who find the routine fits alongside other daily medication. Neither is clinically superior; this is purely about what makes adherence easiest for you.
If you want guidance on the full injection technique, our page on how to take semaglutide injections covers site selection, depth and what to do if you notice a small bubble under the skin after your Wegovy injection.
A single dose taken a few hours off your usual time is not a clinical problem. Missing a dose entirely is more significant. The general guidance (and you should confirm this with your prescriber or check your Patient Information Leaflet) is straightforward: if more than two days remain before your next scheduled injection, take the missed dose as soon as you remember. If you are within two days of your next injection, skip the missed dose and pick up your usual schedule. Never double-dose to compensate.
Nausea and other gastrointestinal effects are most common in the 24 hours after an injection; some people plan low-demand days accordingly. If side effects feel worse after a dose, it may reflect a gap that was longer than usual, since the medicine has been at a lower level in your system. Consistent timing helps keep that profile predictable.
Wegovy is a Black Triangle medicine, meaning the MHRA monitors it with additional vigilance. If you experience something unexpected (severe or persistent nausea, vomiting that is preventing you from keeping fluids down, or severe stomach pain) contact your prescriber. Suspected side effects can also be reported directly through the Yellow Card scheme.
The titration schedule for Wegovy moves gradually: 0.25 mg for the first four weeks, then 0.5 mg, 1 mg, 1.7 mg, and finally the 2.4 mg maintenance dose, each step at roughly monthly intervals. Your prescriber sets this pace, and the weekly injection day stays constant throughout. Sticking to the same day matters just as much in these early weeks, possibly more, because the starter doses are calibrated to let your system adjust with minimal disruption.
When the pen arrives (a plain, unbranded box from DPD with a tracking notification on your phone) it goes straight into the fridge at 2–8°C. Your prescriber and the Patient Information Leaflet will give you the exact window for keeping it at room temperature once you remove it. The pen is pre-filled, so the mechanics are simple; if you would like a clear walkthrough of the process, our guide on how to take semaglutide is worth reading before your first injection to help embed that timing habit early.
Cost is sometimes a consideration when deciding how consistently to use the medicine. Our Wegovy price guide sets out what private treatment involves financially, so you can plan ahead rather than miss doses because of unexpected expense. For a broader look at the treatment itself, the Wegovy overview page covers eligibility, clinical evidence and what to expect month by month.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.